Europe botanical and plant derivative drug market was valued to be at $5144 million in 2017. The market is projected to grow at a CAGR of 7.96%, generating $9820 million by the end of the forecast period of 2018-2026. United Kingdom, France, Germany, Spain, Italy and the rest of Europe are the markets analyzed for this region. The European market is driven by growing adoption of traditional and plant-based medicines, heavy investments in R&D activities for botanical medicines, and the rising prevalence of asthma in the European countries, especially Germany.

EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026

Europe Botanical and Plant Derivative Drug Market by Types (Terpenes, Steroids, Glycosides, Phenols & Other Types) by Therapeutic Applications (Oncology, Dermatology, Cns Disorders, Hormone Diseases, & Other) by Products & Geography

Request free sample

Europe botanical and plant derivative drug market was valued to be at $5144 million in 2017. The market is projected to grow at a CAGR of 7.96%, generating $9820 million by the end of the forecast period of 2018-2026.

Europe Botanical and Plant Derivative Drug Market

To learn more about this report, request a free sample copy

United Kingdom, France, Germany, Spain, Italy and the rest of Europe are the markets analyzed for this region. The European market is driven by the growing adoption of traditional and plant-based medicines, heavy investments in R&D activities for botanical medicines, and the rising prevalence of asthma in the European countries, especially Germany. The market is classified according to therapeutic applications, types, and products. Germany is expected to exhibit the fastest growth over the forecast period. These drugs are used for treating various respiratory diseases, central nervous system disorders, and cardiovascular diseases. Products like herbal/traditional topical analgesics are gaining demand in this market. Although the prospects look good, the presence of substitute drugs in the market and certain toxicity-related concerns regarding these drugs might hamper the market growth in the future.

Some of the noted companies in this botanical and plant derivative drug market include Novartis International Ag, Analyticon Discovery Gmbh, Glenmark Pharmaceuticals Ltd, Bayer Healthcare Llc, Indena Viale Ortles, Ranbaxy Laboratories Ltd, Bristol-Myers Squibb, Tasly Pharmaceuticals Inc, Boehringer Ingelheim, GlaxoSmithKline, Abbott Laboratories, Piramal Phytocare Ltd, Cura Pharm, Bionova, Lupin Ltd and others.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • GLYCOSIDES IS A QUICKLY RISING MARKET IN TERMS OF TYPES
        • ONCOLOGY HOLDS THE LARGEST MARKET SHARE IN TERMS OF THERAPEUTIC APPLICATION
        • DEMAND FOR HERBAL/TRADITIONAL TOPICAL ANALGESICS PRODUCT IS GROWING RAPIDLY
    1. MARKET DYNAMICS
      • DRIVERS
        • GROWING APPLICATIONS IN DISEASES
        • GROWING FDA APPROVALS
        • TECHNOLOGICAL DEVELOPMENT IN THE MANUFACTURING PROCESS
        • RISING DEMAND FOR TRADITIONAL MEDICINES
        • GROWING FOCUS TOWARDS NATURAL SOURCE MEDICINES
      • RESTRAINTS
        • STRINGENT REGULATIONS REGARDING THE USE AND APPROVAL OF BOTANICAL DRUGS
        • LIMITED ADOPTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
      • OPPORTUNITIES
        • RISING FDA APPROVALS FOR BOTANICAL DRUGS
        • ESCALATING USAGE OF BOTANICAL DRUGS
      • CHALLENGES
        • PRESENCE OF SUBSTITUTES FOR BOTANICAL & PLANT DERIVATIVE DRUG
        • TOXICITY RELATED ISSUES AND SAFETY CONCERNS
    1. MARKET SEGMENTATION
      • MARKET BY TYPES 2018-2026
        • TERPENES
        • STEROIDS
        • GLYCOSIDES
        • PHENOLS
        • OTHER TYPES
      • MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
        • ONCOLOGY
        • DERMATOLOGY
        • CNS DISORDERS
        • HORMONE DISEASES
        • OTHER THERAPEUTIC APPLICATIONS
      • MARKET BY PRODUCTS 2018-2026
        • HERBAL/TRADITIONAL TOPICAL ANALGESICS
        • HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
        • HERBAL/TRADITIONAL DIGESTIVE REMEDIES
        • HERBAL/TRADITIONAL DERMATOLOGICAL
        • HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
        • HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
        • HERBAL/TRADITIONAL TONICS
    1. KEY ANALYTICS
      • MANUFACTURING PROCESS
      • VALUE CHAIN ANALYSIS
      • LEGAL, POLICY AND REGULATORY FRAMEWORK
      • PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRANTS
        • THREATS OF SUBSTITUTE PRODUCT
        • BARGAINING POWER OF BUYER
        • BARGAINING POWER OF SUPPLIER
        • INTENSITY OF COMPETITIVE RIVALRY
      • KEY BUYING CRITERIA
    2. GEOGRAPHIC ANALYSIS
      • EUROPE
        • UNITED KINGDOM
        • FRANCE
        • GERMANY
        • SPAIN
        • ITALY
        • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIES
        • MERGER & ACQUISITION
        • PARTNERSHIP & COLLABORATION
        • EXPANSION & INVESTMENT
      • MARKET SHARE ANALYSIS
      • KEY COMPANIES ANALYSIS
    2. COMPANY PROFILE
      • ABBOTT LABORATORIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • ANALYTICON DISCOVERY GMBH
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • BAYER HEALTHCARE LLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • BOEHRINGER INGELHEIM
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • BIONOVA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • BRISTOL-MYERS SQUIBB
        • OVERVIEW
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • CURA PHARM
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • WILLMAR SCHWABE GMBH & CO. KG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • ELI LILLY AND COMPANY
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • GLAXOSMITHKLINE
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • GLENMARK PHARMACEUTICALS LTD.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • INDENA VIALE ORTLES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • LUPIN LTD
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • MEDIGENE
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • NOVARTIS INTERNATIONAL AG
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
      • PFIZER
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • PIRAMAL PHYTOCARE LTD.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • RANBAXY LABORATORIES LTD (ACQUIRED BY SUN PHARMACEUTICALS LTD)
        • OVERVIEW
        • PRODUCTION PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • SANOFI
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
      • TASLY PHARMACEUTICALS INC.
        • OVERVIEW
        • PRODUCTION PORTFOLIO
        • SCOT ANALYSIS

     

    TABLE LIST

    TABLE 1       EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET, 2018-2026 ($ MILLION)

    TABLE 2       EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY TYPES 2018-2026 ($ MILLION)

    TABLE 3       EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES, 2018-2026 ($ MILLION)

    TABLE 4       EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2018-2026 ($ MILLION)

    TABLE 5       EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES, BY GEOGRAPHY 2018-2026 ($ MILLION)

    TABLE 6       EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS, 2018-2026 ($ MILLION)

    TABLE 7       EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)

    TABLE 8       EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)

    TABLE 9       EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY, 2018-2026 ($ MILLION)

    TABLE 10     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY, 2018-2026 ($ MILLION)

    TABLE 11     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS, 2018-2026 ($ MILLION)

    TABLE 12     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE, 2018-2026 ($ MILLION)

    TABLE 13     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)

    TABLE 14     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET, BY PRODUCT 2018-2026 ($ MILLION)

    TABLE 15     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS, 2018-2026 ($ MILLION)

    TABLE 16     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES, 2018-2026 ($ MILLION)

    TABLE 17     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES, 2018-2026 ($ MILLION)

    TABLE 18     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS, 2018-2026 ($ MILLION)

    TABLE 19     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS, 2018-2026 ($ MILLION)

    TABLE 20     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS, 2018-2026 ($ MILLION)

    TABLE 21     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS, 2018-2026 ($ MILLION)

    TABLE 22     EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

               

    FIGURE LIST

    FIGURE 1     EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)

    FIGURE 2     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES 2018-2026 ($ MILLION)

    FIGURE 3     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2018-2026 ($ MILLION)

    FIGURE 4     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)

    FIGURE 5     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS 2018-2026 ($ MILLION)

    FIGURE 6     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)

    FIGURE 7     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY 2018-2026 ($ MILLION)

    FIGURE 8     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY 2018-2026 ($ MILLION)

    FIGURE 9     EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS 2018-2026 ($ MILLION)

    FIGURE 10   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE 2018-2026 ($ MILLION)

    FIGURE 11   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)

    FIGURE 12   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS 2018-2026 ($ MILLION)

    FIGURE 13   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES 2018-2026 ($ MILLION)

    FIGURE 14   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES 2018-2026 ($ MILLION)

    FIGURE 15   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS 2018-2026 ($ MILLION)

    FIGURE 16   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)

    FIGURE 17   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)

    FIGURE 18   EUROPE BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS 2018-2026 ($ MILLION)

    FIGURE 19   EVOLUTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS

    FIGURE 20   UNITED KINGDOM BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

    FIGURE 21   FRANCE BOTANICAL &  PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

    FIGURE 22   GERMANY BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

    FIGURE 23   SPAIN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

    FIGURE 24   ITALY BOTANICAL PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

    FIGURE 25   REST OF EUROPE BOTANICAL &PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)

    FIGURE 26   BOTANICAL & PLANT DERIVATIVE DRUG MARKET SHARE 2017

    1. GEOGRAPHIC ANALYSIS
      • EUROPE
        • UNITED KINGDOM
        • FRANCE
        • GERMANY
        • SPAIN
        • ITALY
        • REST OF EUROPE
    1. MARKET SEGMENTATION
      • MARKET BY TYPES 2018-2026
        • TERPENES
        • STEROIDS
        • GLYCOSIDES
        • PHENOLS
        • OTHER TYPES
      • MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
        • ONCOLOGY
        • DERMATOLOGY
        • CNS DISORDERS
        • HORMONE DISEASES
        • OTHER THERAPEUTIC APPLICATIONS
      • MARKET BY PRODUCTS 2018-2026
        • HERBAL/TRADITIONAL TOPICAL ANALGESICS
        • HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
        • HERBAL/TRADITIONAL DIGESTIVE REMEDIES
        • HERBAL/TRADITIONAL DERMATOLOGICAL
        • HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
        • HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
        • HERBAL/TRADITIONAL TONICS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type